$1.14 Billion is the total value of Eversept Partners, LP's 68 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 52.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $121,133,955 | +54.2% | 1,064,446 | -16.2% | 10.61% | +55.8% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $64,735,737 | +21.1% | 232,787 | -8.8% | 5.67% | +22.4% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $24,904,557 | +41.4% | 558,774 | -10.8% | 2.18% | +42.9% |
| HUM | Sell | HUMANA INC | $10,726,489 | -10.2% | 20,911 | -14.9% | 0.94% | -9.3% |
| CYH | Sell | COMMUNITY HEALTH SYS INC NEW | $8,648,614 | -54.5% | 2,001,994 | -77.4% | 0.76% | -54.1% |
| LQDA | Sell | LIQUIDIA CORPORATION | $8,223,116 | +7.9% | 1,290,913 | -7.9% | 0.72% | +8.9% |
| GH | Sell | GUARDANT HEALTH INC | $3,974,709 | -56.9% | 146,129 | -14.8% | 0.35% | -56.5% |
| MRUS | Sell | MERUS N V | $2,855,081 | -48.5% | 184,556 | -33.3% | 0.25% | -47.9% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $2,656,387 | -56.8% | 137,423 | -53.3% | 0.23% | -56.2% |
| CABA | Sell | CABALETTA BIO INC | $2,616,585 | +618.1% | 282,874 | -49.5% | 0.23% | +615.6% |
| A | Sell | AGILENT TECHNOLOGIES INC | $1,780,215 | -31.9% | 11,878 | -44.8% | 0.16% | -31.3% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $1,653,610 | -82.5% | 830,960 | -82.3% | 0.14% | -82.3% |
| XOMA | Sell | XOMA CORP DEL | $1,598,463 | +1.0% | 86,873 | -1.7% | 0.14% | +2.2% |
| ARGX | Sell | ARGENX SEsponsored adr | $1,316,813 | +6.5% | 3,476 | -0.7% | 0.12% | +7.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $439,541 | -86.1% | 43,562 | -69.2% | 0.04% | -86.2% |
| AFMD | Sell | AFFIMED N V | $409,478 | -89.5% | 330,224 | -82.5% | 0.04% | -89.3% |
| GOSS | Sell | GOSSAMER BIO INC | $334,640 | -94.9% | 154,212 | -71.9% | 0.03% | -94.9% |
| Exit | THIRD HARMONIC BIO INCco | $0 | – | -10,000 | -100.0% | -0.02% | – | |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS Icall | $0 | – | -24,000 | -100.0% | -0.05% | – |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -126,826 | -100.0% | -0.10% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -7,233 | -100.0% | -0.13% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -9,125 | -100.0% | -0.15% | – |
| AMN | Exit | AMN HEALTHCARE SVCS INCput | $0 | – | -19,000 | -100.0% | -0.17% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -130,768 | -100.0% | -0.19% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -410,052 | -100.0% | -0.28% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -256,289 | -100.0% | -0.34% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -160,000 | -100.0% | -0.35% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -478,387 | -100.0% | -0.85% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -37,100 | -100.0% | -0.86% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -52,970 | -100.0% | -1.13% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -11,962,744 | -100.0% | -1.13% | – |
| BIIB | Exit | BIOGEN INCput | $0 | – | -50,000 | -100.0% | -1.16% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -206,893 | -100.0% | -1.26% | – |
| ANTM | Exit | ELEVANCE HEALTH INC | $0 | – | -33,040 | -100.0% | -1.30% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -637,139 | -100.0% | -8.35% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -781,700 | -100.0% | -18.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.